Funding Tracker/Rivercell

Seed · Drug Discovery AI · France

Rivercell raises $25M

Announced October 7, 2026

The round

Rivercell announced a Seed round of $25M on October 7, 2026, led by HV. Other participants include HCVC, Alven, Bpifrance Digital Venture.

The SignalParis AI Virtual Cell program predicting how human cells respond to drugs and genetic changes.

What Rivercell does

Builds the data engine and AI world model that predict how human cells respond to treatment.

Rivercell produces interventional, time-resolved, multimodal single-cell data at scale in its own automated wet lab and uses it to train an AI world model of the cell. Launched on October 7, 2026 with a $25 million seed round led by HV, with HCVC, Alven and Bpifrance Digital Venture participating.

Full Rivercell profile
Company
Rivercell
Amount
$25M
Stage
Seed
Announced
October 7, 2026
Led by
HV
Other investors
HCVC, Alven, Bpifrance Digital Venture
Vertical
Drug Discovery AI
Country
France
Headquarters
Paris, France
Founded
2025